1832 Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-266,500
| Closed | -$71.4M | – | 686 |
|
|
2018
Q3 | $71.4M | Buy |
266,500
+12,100
| +5% | +$3.24M | 0.23% | 98 |
|
|
2018
Q2 | $51.4M | Buy |
+254,400
| New | +$51.4M | 0.17% | 115 |
|
|
2017
Q4 | – | Sell |
-9,400
| Closed | -$1.24M | – | 714 |
|
|
2017
Q3 | $1.24M | Buy |
+9,400
| New | +$1.24M | ﹤0.01% | 410 |
|
|
2016
Q3 | – | Sell |
-469,700
| Closed | -$55.2M | – | 723 |
|
|
2016
Q2 | $55.2M | Hold |
469,700
| – | – | 0.21% | 108 |
|
|
2016
Q1 | $80.3M | Buy |
+469,700
| New | +$80.3M | 0.2% | 120 |
|